Literature DB >> 11258977

Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens.

H Fang1, W Tong, L M Shi, R Blair, R Perkins, W Branham, B S Hass, Q Xie, S L Dial, C L Moland, D M Sheehan.   

Abstract

Understanding structural requirements for a chemical to exhibit estrogen receptor (ER) binding has been important in various fields. This knowledge has been directly and indirectly applied to design drugs for human estrogen replacement therapy, and to identify estrogenic endocrine disruptors. This paper reports structure-activity relationships (SARs) based on a total of 230 chemicals, including both natural and xenoestrogens. Activities were generated using a validated ER competitive binding assay, which covers a 10(6)-fold range. This study is focused on identification of structural commonalities among diverse ER ligands. It provides an overall picture of how xenoestrogens structurally resemble endogenous 17beta-estradiol (E(2)) and the synthetic estrogen diethylstilbestrol (DES). On the basis of SAR analysis, five distinguishing criteria were found to be essential for xenoestrogen activity, using E(2) as a template: (1) H-bonding ability of the phenolic ring mimicking the 3-OH, (2) H-bond donor mimicking the17beta-OH and O-O distance between 3- and 17beta-OH, (3) precise steric hydrophobic centers mimicking steric 7alpha- and 11beta-substituents, (4) hydrophobicity, and (5) a ring structure. The 3-position H-bonding ability of phenols is a significant requirement for ER binding. This contributes as both a H-bond donor and acceptor, although predominantly as a donor. However, the 17beta-OH contributes as a H-bond donor only. The precise space (the size and orientation) of steric hydrophobic bulk groups is as important as a 17beta-OH. Where a direct comparison can be made, strong estrogens tend to be more hydrophobic. A rigid ring structure favors ER binding. The knowledge derived from this study is rationalized into a set of hierarchical rules that will be useful in guidance for identification of potential estrogens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11258977     DOI: 10.1021/tx000208y

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  61 in total

Review 1.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

2.  Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women.

Authors:  Silvina Levis; Nancy Strickman-Stein; Daniel R Doerge; Jeffrey Krischer
Journal:  Contemp Clin Trials       Date:  2010-03-15       Impact factor: 2.226

Review 3.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

4.  Surrogate docking: structure-based virtual screening at high throughput speed.

Authors:  Sukjoon Yoon; Andrew Smellie; David Hartsough; Anton Filikov
Journal:  J Comput Aided Mol Des       Date:  2005-11-16       Impact factor: 3.686

5.  Benchmarking sets for molecular docking.

Authors:  Niu Huang; Brian K Shoichet; John J Irwin
Journal:  J Med Chem       Date:  2006-11-16       Impact factor: 7.446

6.  Bio-Based Bisfuran: Synthesis, Crystal Structure and Low Molecular Weight Amorphous Polyester.

Authors:  Vishwanath Gaitonde; Kyunghee Lee; Kristin Kirschbaum; Steven J Sucheck
Journal:  Tetrahedron Lett       Date:  2014-07-23       Impact factor: 2.415

7.  Prediction of binding affinity for estrogen receptor alpha modulators using statistical learning approaches.

Authors:  Yonghua Wang; Yan Li; Jun Ding; Yuan Wang; Yaqing Chang
Journal:  Mol Divers       Date:  2008-07-26       Impact factor: 2.943

Review 8.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  Application of screening methods, shape signatures and engineered biosensors in early drug discovery process.

Authors:  Izabela Hartman; Alison R Gillies; Sonia Arora; Christina Andaya; Nitya Royapet; William J Welsh; David W Wood; Randy J Zauhar
Journal:  Pharm Res       Date:  2009-07-22       Impact factor: 4.200

10.  Differential regulation of dopamine transporter function and location by low concentrations of environmental estrogens and 17beta-estradiol.

Authors:  Rebecca A Alyea; Cheryl S Watson
Journal:  Environ Health Perspect       Date:  2009-01-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.